Recently, we reported that CCR2 transduced tumor antigen-specific CD8+ T cell trafficking by CCL2 expression in lung cancer cells, which potentiated its in vivo anti-lung cancer reactivity [22]. The gene discussed is CD8A; the disease is lung carcinoma.